Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). SciBase Holding AB's share price for the quarter that ended in Mar. 2024 was kr0.39. SciBase Holding AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 119.83 Mil. Therefore, SciBase Holding AB's market cap for the quarter that ended in Mar. 2024 was kr46.73 Mil.
SciBase Holding AB's quarterly market cap
declined
from Sep. 2023 (kr148.11 Mil) to Dec. 2023 (kr99.94 Mil) and
declined
from Dec. 2023 (kr99.94 Mil) to Mar. 2024 (kr46.73 Mil).
SciBase Holding AB's annual market cap
declined
from Dec. 2021 (kr377.98 Mil) to Dec. 2022 (kr261.57 Mil) and
declined
from Dec. 2022 (kr261.57 Mil) to Dec. 2023 (kr99.94 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SciBase Holding AB's Enterprise Value for Today is kr48.64 Mil.
SciBase Holding AB Market Cap Historical Data
The historical data trend for SciBase Holding AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of SciBase Holding AB's Market Cap
For the Medical Devices subindustry, SciBase Holding AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SciBase Holding AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Market Cap distribution charts can be found below:
* The bar in red indicates where SciBase Holding AB's Market Cap falls into.
SciBase Holding AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
SciBase Holding AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SciBase Holding AB (OSTO:SCIB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
SciBase Holding AB Market Cap Related Terms
Thank you for viewing the detailed overview of SciBase Holding AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
SciBase Holding AB (OSTO:SCIB) Business Description
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments: skin cancer and skin barrier assessment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:SCIB has been successfully added to your 